NCT03390738 2021-05-03Nivolumab as Treatment for Recurrent/Metastatic Nasopharyngeal Carcinoma After Failing 2 Lines or More Previous ChemotherapyThe University of Hong KongPhase 2 Withdrawn
NCT00367718 2020-05-18Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal CarcinomaJohns Hopkins UniversityPhase 2 Withdrawn